Research programme: coronavirus vaccines - ARTES
Alternative Names: SARS-CoV-2 vaccine candidates - ARTESLatest Information Update: 28 May 2024
At a glance
- Originator ARTES Biotechnology
- Class COVID-19 vaccines; Virus-like particle vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported COVID 2019 infections
Most Recent Events
- 28 May 2024 No recent reports of development identified for research development in COVID-2019-infections in Germany (Parenteral)
- 27 Apr 2020 Early research in COVID-2019 infections in Germany (Parenteral)